Latest Information Update: 09 Nov 2006
At a glance
- Originator Roche
- Class Benzodiazepines
- Mechanism of Action GABA A receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 09 Nov 2006 Discontinued - Clinical-Phase-Unknown for Anxiety disorders in Switzerland (PO)
- 22 Mar 2001 New profile
- 22 Mar 2001 Investigation in Anxiety disorders in Switzerland (PO)